| Today's physicians and health care professionals face new challenges in the area of diagnostic hearing testing. Reimbursement levels are declining while costs are escalating. Many areas of the country are experiencing acute shortages of hearing health professionals as demographics require more patients to receive diagnostic hearing tests. In the United States alone, there are over
31 million people (10% of the population) afflicted with
some hearing loss yet only about 6.1 million of these individuals
have been diagnosed and treated.
There is a crisis in the hearing health industry today and a large unmet market need:
- 10% of the US and global population suffers from hearing loss
- 80% of those in the US with hearing loss do not receive testing and treatment
- Hearing loss is the most common birth defect and the second most common chronic condition effecting the aging
- Over 30% of patients over the age of 65 suffer from hearing loss that requires diagnosis and treatment
- Aging baby-boomers are increasing the population that has hearing loss
- Shortage of audiologists in many markets limits the ability to diagnose and treat hearing loss
- In addition, in several
cases, testing with the Otogram has resulted in the
early discovery and treatment of tumors which, had they
been left untreated, could have resulted in loss of
function (hearing or balance) or even loss of life.
To address these challenges and to provide a solution to the unmet clinical need for diagnosing and treating hearing loss, Tympany, a Texas-based company, invented the OtogramTM - the first and only automated and self-administered comprehensive diagnostic hearing testing equipment.
Tympany brought automation, artificial intelligence and miniaturization to the hearing health industry to meet the large unmet needs of the millions of people who suffer from chronic undiagnosed and untreated hearing loss. Left untreated, hearing loss will lead to depression, social isolation, lower self esteem and decreased earning power.
Tympany's mission is to eliminate the barriers in diagnosing hearing loss. Our
patented product, the OtogramT, is revolutionizing the hearing health industry by allowing physicians, audiologists, hearing instrument specialists, and other health care professionals to efficiently and effectively test and diagnose
patients, with much less effort than ever before. The result? More time to treat their patients' hearing loss and more patients are diagnosed.
Tympany is committed to assisting health care professionals in their mission to improve their patients' hearing health by delivering the four "C"s of our value proposition.
 Tympany's
products will deliver what you care about most: |
 |
Cost |
|
Decrease the cost of diagnosing hearing loss by 75% to its lowest possible level and provide the best value hearing diagnostic solution. |
 |
Convenience |
|
Increase the convenience to patients, physicians, clinicians and other hearing health professional in diagnosing hearing loss and offer unlimited hearing testing in multiple languages. |
|
 |
Confidence |
|
Provide safe, effective, and accurate tools to better diagnose hearing loss |
|
 |
Compensation |
|
Provide innovative tools to allow attractive and fair compensation to healthcare professionals for diagnosing hearing loss. . |
|
|
|
|
|
|
